2024, Allergy Immunotherapy Market Growth, Share, Revenue and Market Share by Manufacturers
To Request Sample Copy of This Report: https://www.qyresearchreports.us/send-an-enquiry/southeast-asia-allergy-immunotherapies-market-research-report-2021
Allergy immunotherapy is also termed as allergy shots, is a prolonged treatment which lessens the symptoms for many people with allergic asthma, allergic rhinitis, conjunctivitis (eye allergy), or stinging insect allergy. These shots diminish the sensitivity towards allergens and frequently result in relief that lasts against the allergy symptoms even when the treatment is stopped. Therefore, it is the most cost-efficient, and beneficial approach for many people. Children as well as adults can receive the allergy immunotherapy, however it is not generally recommended for the children under age five. On the other side, when administering the allergy shots for an adult, health conditions such as cardiac disease must be considered and accordingly discussed with the immunologists. There are two types of immunotherapy – Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy. SCIT is an exclusive therapy for various allergic diseases due to its capability of rendering symptomatic relief at the same time altering disease by aiming at the underlying immunological mechanism. It has been successfully used in the treatment of rhinoconjunctivitis/ rhinitis, stinging insect hypersensitivity, and asthma in several clinical trials that are controlled. Immunotherapy addresses the reason for allergies by providing little doses of what a person is allergic to and this increases the immunity or tolerance level to the allergen and lessens the symptoms of allergies. Sublingual immunotherapy is rendered as drops under the tongue unlike the other injection immunotherapy.
Allergy Immunotherapy in Southeast Asia market, especially in Indonesia, Philippines, Thailand, Malaysia, Singapore and Vietnam, focuses on top players in these countries, with revenue and market share for each player in these regions, covering
ALK
Stallergenes
HAL
Market Segment by Countries, this report splits Southeast Asia into several key Countries, with revenue, market share and growth rate of Allergy Immunotherapy in these regions, from 2011 to 2021 (forecast), like
Indonesia
Philippines
Thailand
Malaysia
Vietnam
Singapore
Split by product types, with revenue, market share and growth rate of each type, can be divided into
Subcutaneous immunotherapy
Sublingual Immunotherapy
Split by applications, this report focuses on sales, market share and growth rate of Allergy Immunotherapy in each application, can be divided into
Allergic Rhinitis
Allergic Asthma
Other
